N. Uskent Et Al. , "Prognostic Significance of Tumor Tissue NeuGcGM3 Ganglioside Expression in Patients Receiving Racotumomab Immunotherapy," Journal of Oncology , vol.2020, 2020
Uskent, N. Et Al. 2020. Prognostic Significance of Tumor Tissue NeuGcGM3 Ganglioside Expression in Patients Receiving Racotumomab Immunotherapy. Journal of Oncology , vol.2020 .
Uskent, N., Ayla, S., Molinas Mandel, N., ÖZKAN, M., Teomete, M., Baloglu, H., ... Aydincer, C.(2020). Prognostic Significance of Tumor Tissue NeuGcGM3 Ganglioside Expression in Patients Receiving Racotumomab Immunotherapy. Journal of Oncology , vol.2020.
Uskent, Necdet Et Al. "Prognostic Significance of Tumor Tissue NeuGcGM3 Ganglioside Expression in Patients Receiving Racotumomab Immunotherapy," Journal of Oncology , vol.2020, 2020
Uskent, Necdet Et Al. "Prognostic Significance of Tumor Tissue NeuGcGM3 Ganglioside Expression in Patients Receiving Racotumomab Immunotherapy." Journal of Oncology , vol.2020, 2020
Uskent, N. Et Al. (2020) . "Prognostic Significance of Tumor Tissue NeuGcGM3 Ganglioside Expression in Patients Receiving Racotumomab Immunotherapy." Journal of Oncology , vol.2020.
@article{article, author={Necdet Uskent Et Al. }, title={Prognostic Significance of Tumor Tissue NeuGcGM3 Ganglioside Expression in Patients Receiving Racotumomab Immunotherapy}, journal={Journal of Oncology}, year=2020}